{"id":"glibenclamide-metformin","safety":{"commonSideEffects":[{"rate":"5–15","effect":"Hypoglycemia"},{"rate":"10–30","effect":"Gastrointestinal disturbance (nausea, diarrhea, abdominal discomfort)"},{"rate":"2–5","effect":"Weight gain"},{"rate":"<0.1","effect":"Lactic acidosis (rare)"},{"rate":"5–10","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Glibenclamide is a sulfonylurea that binds to ATP-sensitive potassium channels on beta cells, triggering insulin release. Metformin is a biguanide that decreases gluconeogenesis and glycogenolysis in the liver and enhances peripheral glucose uptake and utilization. The combination addresses both insulin deficiency and insulin resistance.","oneSentence":"Glibenclamide stimulates insulin secretion from pancreatic beta cells while metformin reduces hepatic glucose production and improves insulin sensitivity, together lowering blood glucose in type 2 diabetes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:14:04.154Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT06907472","phase":"NA","title":"Diabetes Management for Primary Healthcare Centers.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Abuja","startDate":"2025-09-15","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":106},{"nctId":"NCT05220917","phase":"","title":"Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-08-01","conditions":"Cardiovascular Events, Type2 Diabetes, Renal Disease","enrollment":781430},{"nctId":"NCT05910554","phase":"PHASE2","title":"Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis","status":"WITHDRAWN","sponsor":"University of Maryland, Baltimore","startDate":"2025-12-10","conditions":"Sarcoidosis, Pulmonary","enrollment":""},{"nctId":"NCT03029702","phase":"PHASE4","title":"Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus","status":"COMPLETED","sponsor":"Maisa N. Feghali, MD","startDate":"2018-02-28","conditions":"Gestational Diabetes, Diabetes, Gestational, Pregnancy in Diabetes","enrollment":54},{"nctId":"NCT00965991","phase":"NA","title":"Metformin Compared to Glyburide in Gestational Diabetes","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2003-07","conditions":"Gestational Diabetes","enrollment":149},{"nctId":"NCT06589141","phase":"NA","title":"Comparison Between Metformin and Glyburide in the Management of Gestational Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-01-01","conditions":"Gestational Diabetes Mellitus in Pregnancy","enrollment":180},{"nctId":"NCT01107717","phase":"PHASE4","title":"Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2009-01","conditions":"Diabetes","enrollment":318},{"nctId":"NCT06570980","phase":"","title":"Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.","status":"RECRUITING","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2023-08-25","conditions":"Type 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin","enrollment":200},{"nctId":"NCT00835991","phase":"PHASE1","title":"Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2003-02","conditions":"Healthy","enrollment":60},{"nctId":"NCT00836472","phase":"PHASE1","title":"Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2003-04","conditions":"Healthy","enrollment":60},{"nctId":"NCT05688332","phase":"PHASE3","title":"Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients","status":"UNKNOWN","sponsor":"University of Zambia","startDate":"2023-08","conditions":"Diabetes Mellitus Type 2 Without Complication","enrollment":118},{"nctId":"NCT05161429","phase":"","title":"BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2021-07-01","conditions":"Diabetes Mellitus, Type 2","enrollment":550000},{"nctId":"NCT02919345","phase":"PHASE4","title":"Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2017-01","conditions":"Diabetes Mellitus, Type 2, Coronary Artery Disease, Carotid Artery Diseases","enrollment":98},{"nctId":"NCT01131182","phase":"PHASE4","title":"Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-06-13","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":1147},{"nctId":"NCT04859452","phase":"PHASE1","title":"A Study to Evaluate the DDI of DBPR108 With Metformin,Glibenclamide,Valsartan, or Simvastatin in Healthy Subjects","status":"COMPLETED","sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","startDate":"2021-05-26","conditions":"Healthy Subjects","enrollment":56},{"nctId":"NCT02726490","phase":"EARLY_PHASE1","title":"Glyburide vs Glucovance in the Treatment of GDM","status":"TERMINATED","sponsor":"Texas Tech University Health Sciences Center, El Paso","startDate":"2016-07","conditions":"Gestational Diabetes","enrollment":7},{"nctId":"NCT01697592","phase":"PHASE3","title":"Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-10-24","conditions":"Type 2 Diabetes Mellitus","enrollment":585},{"nctId":"NCT03078725","phase":"PHASE4","title":"Failure Rate of GLyburide And Metformin Among Gestational Diabetics","status":"WITHDRAWN","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2017-06-20","conditions":"Gestational Diabetes Mellitus, Class A2","enrollment":""},{"nctId":"NCT01215331","phase":"PHASE3","title":"Gestational Diabetes: Insulin or Oral Hypoglycemic Agents?","status":"COMPLETED","sponsor":"Université de Sherbrooke","startDate":"2010-08","conditions":"Gestational Diabetes Mellitus","enrollment":73},{"nctId":"NCT02627898","phase":"PHASE2","title":"Effect of Green Tea Extract on Arterial Stiffness in Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Centro Universitario de Ciencias de la Salud, Mexico","startDate":"2016-01","conditions":"Type 2 Diabetes Mellitus","enrollment":24},{"nctId":"NCT00232583","phase":"NA","title":"Preservation of Beta-cell Function in Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2003-11","conditions":"Type 2 Diabetes Mellitus","enrollment":58},{"nctId":"NCT00279045","phase":"PHASE3","title":"Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2000-01-03","conditions":"Diabetes Mellitus, Type 2","enrollment":4426},{"nctId":"NCT01822548","phase":"PHASE3","title":"Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes","status":"COMPLETED","sponsor":"Azienda Ospedaliero-Universitaria di Parma","startDate":"2010-10","conditions":"Type 2 Diabetes","enrollment":64},{"nctId":"NCT01340768","phase":"PHASE3","title":"Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-06-22","conditions":"Type 2 Diabetes Mellitus","enrollment":870},{"nctId":"NCT01357135","phase":"","title":"An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2009-07-15","conditions":"Type 2 Diabetes Mellitus","enrollment":3453},{"nctId":"NCT01798706","phase":"PHASE3","title":"Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2013-06","conditions":"Type 2 Diabetes","enrollment":350},{"nctId":"NCT00379769","phase":"PHASE3","title":"RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2001-04","conditions":"Diabetes Mellitus, Type 2","enrollment":4447},{"nctId":"NCT02080377","phase":"PHASE3","title":"A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2014-07","conditions":"Pregnancy, Gestational Diabetes","enrollment":23},{"nctId":"NCT02476760","phase":"","title":"Incretin-based Drugs and Acute Pancreatitis","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2014-03","conditions":"Diabetes Mellitus, Type 2","enrollment":1417914},{"nctId":"NCT01563120","phase":"PHASE4","title":"A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes Mellitus","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2012-01","conditions":"Gestational Diabetes Mellitus","enrollment":108},{"nctId":"NCT01944618","phase":"","title":"forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2013-10","conditions":"Type 2 Diabetes","enrollment":5000},{"nctId":"NCT02145611","phase":"PHASE4","title":"Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension","status":"COMPLETED","sponsor":"Dr. José Fernando Vilela-Martin MD PhD","startDate":"2013-07","conditions":"Type 2 Diabetes Mellitus, Hypertension, Endothelial Dysfunction","enrollment":50},{"nctId":"NCT02456428","phase":"","title":"Incretin-based Drugs and the Risk of Heart Failure","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2014-03","conditions":"Type 2 Diabetes Mellitus","enrollment":1499650},{"nctId":"NCT02475499","phase":"","title":"Incretin-based Drugs and Pancreatic Cancer","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2014-03","conditions":"Diabetes Mellitus, Type 2","enrollment":886172},{"nctId":"NCT00486187","phase":"NA","title":"Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study","status":"COMPLETED","sponsor":"Dr. Milan Gupta","startDate":"2006-04","conditions":"Type 2 Diabetes Mellitus","enrollment":103},{"nctId":"NCT02607410","phase":"PHASE4","title":"Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2010-01","conditions":"Type 2 Diabetes Mellitus","enrollment":40},{"nctId":"NCT00700856","phase":"PHASE4","title":"Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial","status":"UNKNOWN","sponsor":"Italian Society of Diabetology","startDate":"2008-09","conditions":"Type 2 Diabetes Mellitus, Cardiovascular Disease","enrollment":3371},{"nctId":"NCT00313313","phase":"PHASE3","title":"A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2006-04","conditions":"Diabetes","enrollment":768},{"nctId":"NCT01998113","phase":"","title":"Glyburide and Metformin for the Treatment of Gestational Diabetes Mellitus. Systematic Review","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2013-03","conditions":"Gestational Diabetes Mellitus","enrollment":2509},{"nctId":"NCT01329016","phase":"PHASE1, PHASE2","title":"Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)","status":"UNKNOWN","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2011-07","conditions":"Gestational Diabetes Mellitus","enrollment":360},{"nctId":"NCT01584232","phase":"PHASE3","title":"A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2012-04","conditions":"Type 2 Diabetes Mellitus","enrollment":361},{"nctId":"NCT01940302","phase":"EARLY_PHASE1","title":"Dietary Supplement of LEHEL for the Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Shaoguan University","startDate":"2013-06","conditions":"Type 2 Diabetes","enrollment":71},{"nctId":"NCT01867502","phase":"PHASE4","title":"Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2014-04","conditions":"Diabetes Mellitus, Type 2, Hypoglycemic Agents, Diabetic Blood Glucose Monitoring","enrollment":20},{"nctId":"NCT02091336","phase":"PHASE4","title":"Oral Antidiabetic Agents in Pregnancy","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2014-01","conditions":"Gestational Diabetes","enrollment":80},{"nctId":"NCT01195259","phase":"","title":"Malignancy Meta Analysis for BRL49653","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-10","conditions":"Diabetes Mellitus, Type 2","enrollment":1},{"nctId":"NCT00494312","phase":"PHASE4","title":"Safety Study of Pioglitazone Compared To Glyburide on Liver Function","status":"COMPLETED","sponsor":"Takeda","startDate":"2000-10","conditions":"Diabetes Mellitus, Liver","enrollment":2120},{"nctId":"NCT01029795","phase":"PHASE2","title":"A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus","status":"TERMINATED","sponsor":"Eli Lilly and Company","startDate":"2010-02","conditions":"Diabetes Mellitus, Type 2","enrollment":38},{"nctId":"NCT00935805","phase":"","title":"Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2006-07","conditions":"Diabetes Mellitus, Arterial Hypertension","enrollment":124},{"nctId":"NCT01068860","phase":"PHASE2","title":"To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies","status":"COMPLETED","sponsor":"Novartis","startDate":"2010-02","conditions":"Type 2 Diabetes Mellitus, Impaired Glucose Tolerance","enrollment":246},{"nctId":"NCT00770835","phase":"PHASE4","title":"Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.","status":"COMPLETED","sponsor":"Takeda","startDate":"2009-03","conditions":"Diabetes Mellitus","enrollment":39},{"nctId":"NCT00035542","phase":"PHASE3","title":"A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2001-12","conditions":"Diabetes Mellitus, Non-Insulin-Dependent","enrollment":""},{"nctId":"NCT00035568","phase":"PHASE4","title":"A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2002-02","conditions":"Diabetes Mellitus, Non-Insulin-Dependent","enrollment":""},{"nctId":"NCT00046462","phase":"PHASE3","title":"Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment","status":"COMPLETED","sponsor":"Sanofi","startDate":"2001-11","conditions":"Diabetes Mellitus","enrollment":240},{"nctId":"NCT00865436","phase":"PHASE1","title":"A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2004-04","conditions":"Healthy","enrollment":36},{"nctId":"NCT00864734","phase":"PHASE1","title":"A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting Conditions","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2002-11","conditions":"Healthy","enrollment":24},{"nctId":"NCT00865241","phase":"PHASE1","title":"A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2002-11","conditions":"Healthy","enrollment":36},{"nctId":"NCT00417729","phase":"PHASE4","title":"Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DM","status":"COMPLETED","sponsor":"Taichung Veterans General Hospital","startDate":"2007-01","conditions":"Diabetes Mellitus","enrollment":51},{"nctId":"NCT00347100","phase":"PHASE4","title":"Insulin Glargine in Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-06","conditions":"Diabetes Mellitus, Type 2","enrollment":387},{"nctId":"NCT00696982","phase":"NA","title":"The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2008-06","conditions":"Diabetes Mellitus, Arterial Stiffness","enrollment":60},{"nctId":"NCT00541437","phase":"","title":"Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet","status":"COMPLETED","sponsor":"Genovate Biotechnology Co., Ltd.,","startDate":"2006-05","conditions":"Type 2 Diabetes Mellitus","enrollment":12},{"nctId":"NCT00371306","phase":"NA","title":"Comparison of Glucovance to Insulin for Diabetes During Pregnancy","status":"UNKNOWN","sponsor":"Regional Obstetrical Consultants","startDate":"2002-09","conditions":"Gestational Diabetes, Type 2 Diabetes, Pregnancy","enrollment":200}],"_emaApprovals":[],"_faersSignals":[{"count":31,"reaction":"BLOOD GLUCOSE INCREASED"},{"count":17,"reaction":"NAUSEA"},{"count":12,"reaction":"HYPOGLYCAEMIA"},{"count":11,"reaction":"BLOOD GLUCOSE DECREASED"},{"count":11,"reaction":"DRUG INEFFECTIVE"},{"count":11,"reaction":"WEIGHT DECREASED"},{"count":9,"reaction":"ASTHENIA"},{"count":9,"reaction":"DECREASED APPETITE"},{"count":9,"reaction":"DYSPNOEA"},{"count":9,"reaction":"VOMITING"}],"_approvalHistory":[],"publicationCount":44,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Glibenclamide + Metformin","genericName":"Glibenclamide + Metformin","companyName":"University of Zambia","companyId":"university-of-zambia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glibenclamide stimulates insulin secretion from pancreatic beta cells while metformin reduces hepatic glucose production and improves insulin sensitivity, together lowering blood glucose in type 2 diabetes. Used for Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}